ClinicalTrials.gov
ClinicalTrials.gov Menu

Joint Outcome Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00207597
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : September 21, 2005
Sponsor:
Information provided by:
Centers for Disease Control and Prevention

Brief Summary:
This study examines the progression of joint disease in children with hemophilia assigned to either standard treatment or enhanced therapy.

Condition or disease
Hemophilia A

Study Type : Observational
Enrollment : 64 participants
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia
Study Start Date : September 1995
Study Completion Date : August 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Joint Disorders
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year to 30 Months   (Child)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosed with hemophilia A
  • factor level less than 2%

Exclusion Criteria:

  • More than 2 bleeds into the same joint

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00207597


Sponsors and Collaborators
Centers for Disease Control and Prevention
Investigators
Principal Investigator: Marilyn J Manco-Johnson, MD University of Colorado, Denver

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00207597     History of Changes
Other Study ID Numbers: CDC-NCBDDD-1455
U27/CCU812106
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: September 21, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Hemophilia A
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn